4.4 Article

Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus

Related references

Note: Only part of the references are listed.
Article Rheumatology

Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study

Candace H. Feldman et al.

Summary: The study aimed to define a set of SLE-specific adverse outcomes that could be prevented with timely, effective ambulatory care. Through a modified Delphi process, 25 SLE-specific conditions were identified as potentially preventable and important on a population level, falling into categories of vaccine-preventable illnesses, medication-related complications, reproductive health-related complications, and SLE-related complications.

ARTHRITIS CARE & RESEARCH (2021)

Article Rheumatology

Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus

Jessica N. Williams et al.

Summary: This study found that African American and Asian women with SLE have lower odds of contraception dispensing, and African American women have lower odds of highly effective contraception (HEC) use. Further research is needed to understand the factors driving these racial disparities among this population.

ARTHRITIS CARE & RESEARCH (2021)

Review Rheumatology

Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries

Katherine P. Pryor et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)

Article Rheumatology

Avoidable Acute Care Use for Vaccine-Preventable Illnesses Among Medicaid Beneficiaries With Lupus

Candace H. Feldman et al.

Summary: It was found that Medicaid beneficiaries with SLE who are not vaccinated are at risk for potentially avoidable acute care use for vaccine-preventable illnesses, with higher risk among Black patients compared to White patients. Greater outpatient use was associated with reduced risk.

ARTHRITIS CARE & RESEARCH (2021)

Article Rheumatology

Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus

Konstantinos Tselios et al.

Summary: The study found that gradual glucocorticoid withdrawal in patients with clinically quiescent SLE is safe and associated with fewer clinical flares and less damage accrual at 24 months compared to those maintaining a low prednisone dose.

ACR OPEN RHEUMATOLOGY (2021)

Review Immunology

Systemic lupus erythematosus and risk of infection

Megan R. W. Barber et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)

Review Rheumatology

Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus

Shilpa Arora et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)

Review Endocrinology & Metabolism

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus

Irene E. M. Bultink

CALCIFIED TISSUE INTERNATIONAL (2018)

Article Rheumatology

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis

Eli M. Miloslavsky et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Review Rheumatology

Factors associated with access to rheumatologists for Medicare patients

Gabriela Schmajuk et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)

Review Rheumatology

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

Ronald F. van Vollenhoven et al.

ANNALS OF THE RHEUMATIC DISEASES (2014)

Article Rheumatology

Quality of Care for Incident Lupus Nephritis Among Medicaid Beneficiaries in the United States

Jinoos Yazdany et al.

ARTHRITIS CARE & RESEARCH (2014)

Article Medicine, General & Internal

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan

Cindy Garris et al.

JOURNAL OF MEDICAL ECONOMICS (2013)

Article Psychology, Clinical

Group-Based Trajectory Modeling in Clinical Research

Daniel S. Nagin et al.

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)